ENG Gene Variant rs1064792934: What You Should Know

What each genotype means

Understanding the ENG Gene

The ENG gene encodes a protein called endoglin, which is a critical component of the transforming growth factor-beta (TGF-beta) signaling pathway. This pathway is essential for the proper development and maintenance of blood vessels throughout the body. Endoglin is highly expressed in the cardiovascular system, where it helps regulate the structure and stability of capillaries and larger vessels. When the ENG gene is altered, the resulting protein may not function correctly, which can disrupt normal vascular development. This disruption is the underlying cause of hereditary hemorrhagic telangiectasia (HHT), a multisystemic vascular disorder characterized by the formation of abnormal connections between arteries and veins, known as arteriovenous malformations. These malformations can occur in various organs, including the lungs, brain, and gastrointestinal tract, potentially leading to complications such as bleeding or shunting of blood.

What is the rs1064792934 Variant?

The rs1064792934 variant is a specific change in the DNA sequence located within the ENG gene. In genomics, a variant like this represents a single point in the genetic code where the nucleotide base differs from the most common sequence found in the general population. Because this variant sits within the coding region of the ENG gene, researchers investigate whether it alters the structure or function of the endoglin protein. Variants in this gene are often studied in the context of HHT, as loss-of-function mutations are a well-established cause of the condition. While some variants are clearly pathogenic, others may have uncertain effects. Scientific databases track these variants to help clinicians and researchers understand their potential impact on health. It is important to note that the presence of a variant does not automatically mean an individual will develop a specific condition, as genetic expression can be complex and influenced by other factors.

Research and Evidence Strength

The evidence linking variants in the ENG gene to hereditary hemorrhagic telangiectasia is robust, as the gene is a primary focus for HHT research. Clinical guidelines, such as those provided by the ACMG/AMP, are used to classify variants based on their likelihood of causing disease. For many variants in ENG, evidence is gathered through family studies, functional assays, and population-scale genomic databases. However, the strength of evidence for any specific variant, including rs1064792934, can vary. Some variants are well-documented as pathogenic, while others are classified as variants of uncertain significance (VUS) because there is not yet enough clinical or functional data to confirm their impact. Researchers continue to analyze large-scale datasets to better understand the spectrum of ENG variants and their correlation with clinical phenotypes. If you have questions about a specific genetic report, it is essential to discuss the findings with a genetic counselor or a medical professional who can interpret the results in the context of your personal and family health history.

Population Frequency

The rs1064792934 variant is classified as rare in the general population. Large-scale genomic databases, such as gnomAD, are used to estimate how frequently specific variants appear across different ancestral groups. Because HHT itself is a rare disorder, the variants that cause it are typically found at very low frequencies in the general population. While some studies suggest that the genetic prevalence of HHT-associated variants may be higher than previously estimated due to underdiagnosis, individual variants like rs1064792934 remain uncommon. Understanding the frequency of a variant helps researchers determine its potential contribution to disease prevalence. If a variant is extremely rare, it may be more difficult to gather sufficient clinical data to definitively classify its pathogenicity, which is why ongoing research and data sharing between clinical laboratories and public databases are vital for improving diagnostic accuracy.

Managing Genetic Information

Genetic information can be complex, and it is important to approach it with the right perspective. Knowing that you carry a specific variant in the ENG gene does not serve as a medical diagnosis. HHT is a clinical diagnosis that involves specific physical symptoms and medical evaluations, not just a genetic test result. If you have received information about a variant, you should not make any changes to your health management or medical care without consulting a qualified healthcare provider. A clinician can help you understand what the variant means for you, whether further testing is necessary, and how to monitor your health appropriately. Genetic counselors are specifically trained to help individuals navigate these findings, providing support and clarity regarding the implications for you and your family members. Always rely on professional medical advice rather than interpreting genetic data on your own.

Frequently asked questions

Sources & further reading

Related variants in ENG